A Mexico-based influencer is promoting peptides as "human biotechnology" that can reprogram your genetics and deliver massive weight loss. The claims mix real research with serious exaggerations.
What does this video actually claim?
@csbiomx calls traditional supplements "the past" and positions peptides as advanced biotechnology. They claim something called "r3ta" is a triple hormone agonist that delivers 28.7% average weight loss based on clinical trials.
They also promote GHK-Cu as a copper peptide that "reprograms genetic expression" for regeneration and superior collagen synthesis. The post references studies from NEJM 2023 and mentions a "Phase 3 TRIUMPH" trial from 2025.
The language is deliberately technical and futuristic. Terms like "human engineering" and "genetic reprogramming" make these compounds sound like cutting-edge medical technology rather than experimental peptides with limited research.
Does the research support these weight loss numbers?
The 28.7% weight loss figure appears inflated compared to published data. The creator likely references tirzepatide, which targets GIP and GLP-1 receptors (though not glucagon as they suggest).
The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) found 22.5% weight loss with 15mg tirzepatide at 72 weeks. That's substantial but not 28.7%. The study they cite from 2023 doesn't exist in NEJM with those specific numbers.
The "Phase 3 TRIUMPH 2025" reference is problematic since we're currently in 2024. Clinical trials don't cite future publications. This suggests the creator is either confused about timeline or making up references.
What about the genetic reprogramming claims?
GHK-Cu does increase collagen production and has wound healing properties, but "reprogramming genetic expression" overstates the evidence. Small studies show it can influence some gene pathways related to tissue repair.
Pickart et al. (2012) found GHK-Cu affected expression of about 4,000 genes in cultured skin cells. But jumping from cell culture to "genetic reprogramming" in humans is a massive leap that ignores how preliminary this research remains.
The peptide community often treats these compounds like precision medicine when the reality is much messier. Most research consists of small studies, animal models, or cell culture work that hasn't been replicated in large human trials.
What's the real regulatory status here?
None of these peptides are approved medications in most countries. They exist in a regulatory gray zone where they're sold as "research chemicals" but marketed for human use.
Tirzepatide is FDA-approved as Mounjaro and Zepbound, but only through legitimate healthcare providers. The version being promoted here likely comes from compounding pharmacies or research chemical suppliers with no quality guarantees.
The "biotechnology" framing makes these sound more legitimate than they are. You're essentially buying experimental compounds with minimal safety data, not approved medical treatments.
What should you actually know?
GLP-1 and dual hormone agonists do work for weight loss, but through legitimate medical channels with proper monitoring. The 15-25% weight loss seen in clinical trials is genuinely impressive.
However, these aren't magic bullets that "reprogram" your biology. They're tools that work alongside diet and lifestyle changes, often with significant side effects like nausea and gastrointestinal issues.
If you're interested in these approaches, work with a healthcare provider who can prescribe approved versions and monitor your response. The underground peptide market offers no safety net if something goes wrong.